These live and on-demand programs are presented by companies serving the AABB community and target a critical need in the field that can be addressed by the sponsor’s solutions technology. Registration is complimentary to all. Continuing education credit is not available.
Improved Blood Availability with the INTERCEPT® Blood System, Pathogen Reduction System
Presented by Cerus Corporation
Held: November 30, 2022 (on-demand available)
Should Clinical Microbiology Labs Perform Sterility Testing of Cell & Gene Therapy Products?
Presented by bioMérieux
Held: September 8, 2022 (on-demand available)
The Impact of Red Blood Cell Transfusions on Biomarkers of Hemorrhagic Shock and Traumatic Brain Injury
Presented by Hemanext®, an AABB Premium Corporate Partner
Held: May 5, 2022 (on-demand available)
Benefits of Early Fibrinogen Supplementation & Experience with Pathogen Reduced Cryoprecipitated Fibrinogen Complex (INTERCEPT® Fibrinogen Complex)
Presented by Cerus Corporation
Held: April 28, 2022 (on-demand available)
Cornell and UCLA Medical Centers Assess Safety and Efficacy of Pathogen Reduced (PR) Platelets
Presented by Cerus Corporation
Held: March 24, 2022 (on-demand available)
Support the AABB Community through Corporate Sponsored Education
Interested in sponsoring a forum? If so, please reach out to us at mboraz@aabb.org.
4550 Montgomery Avenue
Suite 700, North Tower
Bethesda, MD 20814
301.907.6977
